Zamani Mitra, Panahi-Bazaz Mahmoodreza, Assadi Mona
Ophthalmic Infections Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
J Ophthalmic Vis Res. 2015 Jan-Mar;10(1):16-20. doi: 10.4103/2008-322X.156087.
To evaluate the efficacy of corneal collagen cross-linking (CXL) for treatment of corneal ulcers not responding to antimicrobial therapy.
Eight patients with corneal ulcers associated with corneal melting, not responding to conventional antibiotic therapy, were treated with CXL. The procedure was performed according to the standardized protocol for keratoconus. Preoperative medications were continued after CXL in all cases. Microbiological exams revealed Pseudomonas aeruginosa in 3 cases. Follow up continued from 1 to 10 months.
In 6 of 8 eyes, progression of corneal melting was halted and complete epithelialization occurred. In one eye emergency keratoplasty was needed due to corneal perforation. A conjunctival flap was performed to treat severe localized corneal thinning in one of the patients a few days after CXL. Significant clinical improvement occurred in all cases of Pseudomonas aeruginosa keratitis.
CXL can be considered as a promising new treatment in the management of refractory non-healing corneal ulcers, including Pseudomonas aeruginosa keratitis.
评估角膜胶原交联术(CXL)治疗对抗菌治疗无反应的角膜溃疡的疗效。
8例伴有角膜溶解且对抗生素治疗无反应的角膜溃疡患者接受了CXL治疗。该手术按照圆锥角膜的标准化方案进行。所有病例在CXL后继续使用术前药物。微生物学检查显示3例为铜绿假单胞菌感染。随访持续1至10个月。
8只眼中有6只眼的角膜溶解进展停止,角膜完全上皮化。1只眼因角膜穿孔需要紧急角膜移植术。1例患者在CXL几天后进行了结膜瓣手术以治疗严重的局限性角膜变薄。所有铜绿假单胞菌性角膜炎病例均有显著的临床改善。
CXL可被视为治疗难治性不愈合角膜溃疡(包括铜绿假单胞菌性角膜炎)的一种有前景的新疗法。